Mucinous tubular and spindle cell carcinoma and solid variant papillary renal cell carcinoma: a clinicopathologic comparative analysis of four cases with similar molecular genetics datum by Yanling Zhang et al.
Zhang et al. Diagnostic Pathology 2014, 9:194
http://www.diagnosticpathology.org/content/9/1/194CASE REPORT Open AccessMucinous tubular and spindle cell carcinoma and
solid variant papillary renal cell carcinoma: a
clinicopathologic comparative analysis of four
cases with similar molecular genetics datum
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Mucinous tubular and spindle cell carcinoma (MTSC) was first recognized as a specific entity in the World Health
Organization 2004 classification. The “classic” tumor presentation includes an extracellular blue-gray mucinous/myxoid
matrix accompanying the typical tubular and spindle cell epithelial components. Tubules are lined by cuboidal to
columnar cells with bland nuclei, central small to medium sized nucleoli, and few to no mitoses. By expanding the
histologic spectrum, a number of studies highlighted the distinction between MTSC and solid variant of papillary
renal cell carcinoma (sPRCC), although controversy still exists. Here, we evaluated two cases of MTSC and compared
two cases of sPRCC by light microscopy, special staining, immunohistochemical staining and fluorescence in situ
hybridization (FISH). We found that morphologic and immunophenotyping features showed more overlap between
MTSC and sPRCC. In addition, gains of chromosomes 7 and 17 and loss of Y, which are characteristic of PRCC, were
observed in two cases of sPRCC and one case of MTSC, suggesting that MTSC is similar to sPRCC or may be a
subtype of PRCC.
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Mucinous tubular and spindle cell carcinoma (MTSC)
was first recognized as a specific entity in the World
Health Organization 2004 classification [1]. The “classic”
tumor presentation includes an extracellular blue-gray mu-
cinous/myxoid matrix accompanying the typical tubular
and spindle cell epithelial components. Tubules are lined
by cuboidal to columnar cells with bland nuclei, central
small to medium sized nucleoli, and few to no mitoses.
Solid variant of papillary renal cell carcinoma (sPRCC) is
a rare variant of papillary renal cell carcinoma that was first
recognized by Renshaw et al. [2]. Whole tumor cells are ar-
ranged in solid sheets or tubular structures and foci are* Correspondence: 273513439@qq.com
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unless otherwise stated.tightly packed mimicking spindle cells, with no true papil-
lary structure or <20% of the volume of the tumor [3,4].
With the expansion of the histologic spectrum, MTSC
with unusual morphology has also been reported, such as
“mucin-poor” MTSC [5], “MTSC with prominent papillary
component” [6], “spindle cell predominant” or “tubular
predominant” MTSC [7], psammoma bodies and macro-
phages are detected in the stroma [5,7]. Morphologic over-
lap between MTSC and sPRCC has been reported, and a
number of studies highlighted the distinction between
MTSC and sPRCC, such as Paner et al. [8], who consid-
ered that MTSC and sPRCC with sarcomatous change can
be distinguished by the spindle cell component with atypia.
Argani et al. [9] reported five cases of sPRCC accom-
panying low-grade spindle cell tumors, a morphology
that is difficult to distinguish from MTSC, howeverLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinicopathologic features of 4 cases
Tumor
type




MTSC 1 71 Male 3.5 cm T1aN0 14
2 75 Female 6.0 cm T1bN0 13
sPRCC 3 50 Male 2.0 cm T1aN0 12
4 51 Male 8.0 cm T2N0 8
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http://www.diagnosticpathology.org/content/9/1/194molecular genetic studies revealed gains of chromosomes
7 and 17 and loss of the Y chromosome, supporting the
diagnosis of sPRCC. Fine et al. [10] suggested that MTSC
and sPRCC have a morphologic and immunophenotypic
overlap, but molecular genetics studies could distin-
guish between MTSC and sPRCC. Shen et al. [7] sug-
gested that MTSC is a subtype of PRCC based on
morphological and immunohistochemical results. How-
ever, there is still ambiguity in the relationship between
MTSC and sPRCC [11]. Therefore, we compared two
cases of MTSC and two cases of sPRCC in terms of
morphology, immunohistochemistry and molecular genet-
ics, and explored the relationship between MTSC and
sPRCC.
Case presentation
Table 1 lists the demographic and clinical information
for the MTSC and sPRCC cases examined. Case 1
(MTSC) was a 71 year-old man admitted to the hospital
for flank pain. Ultrasound showed a substantive mass
suspicious of renal carcinoma. Another MTSC patient
(case 2) was a 75 year-old woman, who presented with
computed tomography findings showing a solid mass in
the right kidney that was considered potentially malig-
nant. Two cases of sPRCC (cases 3 and 4) were men, 50
and 51 years-old, respectively. Computed tomography
showed that case 3 had a space-occupying lesion in the
right kidney that was considered potentially malignant
and case 4 had a substantive lesion in the right kidney.Figure 1 Macroscopic observation and CT findings of MTSC and sPRC
greyish-white cut surface accompanied with hemorrhage and necrosis. (b): s
cut surface (arrow). c): Computed tomography revealed a mass in the renal coRadical resection of the kidney was performed in all four
cases. All four cases showed well-defined nodular masses
of 3.5, 6.0, 2.5 and 8.0 cm in diameter. The cut surfaces
were greyish-white in color. Cases 1 and 3 showed
hemorrhage and necrosis in central regions. Cases 1, 2,
and 3 were staged as T1 tumors and case 4 as T2 (Figure 1,
Table 1).
Methods
Immunohistochemistry and special staining
The collected specimens were fixed with 10% neutral
buffered formalin and embedded in paraffin blocks. Tis-
sue blocks were cut into 4-μm slides, deparaffinized in
xylene, rehydrated with a graded alcohol series, and im-
munostained with the following antibodies: AMACR/
P504S, CK, CK7, CK19, vimentin, CK (H), EMA, E-
cadherin, CD10, CD15, RCC, CD56, NSE, Syn, CgA and
villin. Sections were stained using a streptavidin-peroxidase
system (KIT-9720, Ultrasensitive TM S-P, MaiXin, China).
The chromogen used was diaminobenzidine tetrahydro-
chloride substrate (DAB kit, MaiXin), and sections were
slightly counterstained with hematoxylin, dehydrated and
mounted. Histochemical staining for Alcian blue at pH 2.5
was performed on sections from a block representing the
predominant histology of each case. Immunohistochemical
data are summarized in Table 2.
Fluorescence in situ hybridization and in situ
hybridization analysis
The four cases were examined for their cytogenetic pro-
file. A combination of probe 1 [CSP3 (green), CSP7 (blue)
and CSP17 (red)] and centromeric probe 2 for chromo-
somes X (green) and Y (red) (Guangzhou LBP Medical
Science Technology Co., Ltd., Guangzhou, China) was
used. Each probe was diluted at 1:100 in tDenHyb1 buffer
(Guangzhou LBP Medical Science Technology Co., Ltd.).
Ten microliters of diluted probe was applied to each slide,
and coverslips were placed over the slides. DenaturationC. (a): MTSC (case 2) showed a well-defined nodular mass with a
PRCC (case 3) showed a well-defined nodular mass with a greyish-white
rtex in case 3 that was well-defined (arrow).
Table 2 Sources and dilutions of the antibodies used in
immunohistochemistry
RCC Monoclonal, clone PN-15,1:20(MaiXin, China)
AMACR Monoclonal, clone 13H4,1:100(MaiXin, China)
CK Monoclonal, clone AE1/AE3,1:100(MaiXin, China)
CK7 Monoclonal, clone OV-TL12/30,1:40(MaiXin, China)
CK19 Monoclonal, clone A53-B/A2.26,1:25(MaiXin, China)
vimentin Monoclonal, clone V9,1:20(MaiXin, China)
HMWK Monoclonal, clone 34βE12,1:10(MaiXin, China)
EMA Monoclonal, clone E29,1:200(MaiXin, China)
E-cadherin Monoclonal, clone 4A2C7,1:100(MaiXin, China)
CD10 Monoclonal, clone 56C6,1:10(MaiXin, China)
Ki-67 Monoclonal, clone MIB-1,1:100(MaiXin, China)
CD15 Monoclonal, clone Carb-3,1:100(MaiXin, China)
villin Monoclonal, clone CWWB1,1:25(MaiXin, China)
CD56 Monoclonal, clone 56C04,1:20(MaiXin, China)
NSE Monoclonal, clone E27, 1:100(MaiXin, China)
CgA Monoclonal, clone 5p12, 1:100(MaiXin, China)
Syn Monoclonal, clone SYP02 ,1:40(MaiXin, China)
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in a humidified box, and hybridization was performed at
37°C for 3 h. The coverslips were then removed, and the
slides were immersed at room temperature in 0.5× SSC
for 2 min, in 50% formamide/1× SSC for 5 min, and in 2×
SSC for 2 min. The slides were air-dried and counter-
stained with 10 μL DAPI/Antifade (DAPI in Fluorguard,
0.5 μg/mL; Insitus, Albuquerque, NM, USA). The slides
were examined using an Olympus IX-50 microscope
(Olympus, Tokyo, Japan) with filters. Probe 1 was used
for detection of chromosomes 7 (blue) and 17 (red), and
CSP3 (green) was used as internal control. Probe 2 was
used for detection of chromosome Y (red), and the centro-
meric probe X (green) was used as internal control.
Only individual and well-delineated cells were scored.
Overlapping cells were excluded from the analysis. Ap-
proximately 60 tumor cells were analyzed in the targetedFigure 2 Histological and immunohistochemical findings of MTSC. (a)
epithelial components and extracellular mucinous/myxoid matrix were sign
cells were positive for NSE in cases of MTSC.region. Using established criteria [12], chromosomal gains
were considered significant if present in >20% of cells.
Gains were considered artifactual if seen in <20% of cells.
We used normal kidney tissue to determine the cutoffs.
None of the control kidneys in our study demonstrated
trisomic cells.
This study was approved by the Ethics Committees of
the First Affiliated Hospital of Bengbu Medical College
and conducted in accordance with the ethical guidelines
of the Declaration of Helsinki.
Results
Histologically, two cases of MTSC showed “classical”
morphology. Both of them were predominantly com-
posed of tubular areas with a focal spindle cell appear-
ance, tubules were lined by cuboidal cells with bland
nuclei, central small-to-medium sized nucleoli, Fuhrman
nuclear grade 2 and few to no mitoses. Extracellular
mucinous/myxoid matrix were prominent. Foci papillary
structure was seen in case 1 with accumulation of foam
cells and the accumulation of foam cells could also be
seen in the mucinous stroma; lymphoid aggregates were
observed in case 2. No cases had psammoma bodies
(Figure 2).
A fibrous septum was detected and predominantly
tubular structure were seen in two cases of sPRCC.
Tumor cells were cuboidal or oval with vacuolated chro-
matin and Fuhrman nuclear grade 2–3. Small nucleoli
were observed in focal cells, with scarce light acidophilus
cytoplasm. Nuclear grooves were also observed in several
cells. Psammoma bodies and accumulation of foam cells
were seen in the stroma. Papillary architecture was ob-
served at the edge of the neoplasm, although they occu-
pied <5% of the volume of the tumor. Focal tightly packed
tubular structures of arranged in solid sheets showed simi-
larities to spindle cells was seen in case 3. Alcian blue
staining showed a focal area of mucin in case 3, although
HE staining was inconspicuous (Figure 3).
Immunohistochemical findings showed that the tumor
cells in all four cases were positive for AMACR, CK,: the tumor cells are arranged in tubules accompanying spindle cell
ificant; foci papillary structure was seen in case 1 (arrow). (b): Tumor
Figure 3 Histological and immunohistochemical findings of sPRCC. (a): In cases of sPRCC, the tumor cells are arranged in a tubular pattern
(×4). (b): Nuclear grooves are observed in several cells (arrow) (×40). (c): A fibrous septum is observed in cases of sPRCC (×4). (d): The cells form
solid sheets compressed against each other and have a spindle cell appearance (×40). (e): Foci of mucin are found in case 3 (Alcian blue staining, ×10).
(f): Tumor cells were positive for AMACR in cases of both MTSC and sPRCC.
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Ki - 67 index was <5%. Other markers such as CD15,
CD56, CgA, Syn and villin were negative in both. The
two cases of MTSC were positive for NSE and negative
for CD10 and RCC, whereas the two cases of sPRCC
were negative for NSE, and only case 4 was CD10 and
RCC positive. Alcian blue staining showed large amounts
of mucin resembling mucinous stroma in two cases of
MTSC and small amounts of mucin in the stroma of one
case of sPRCC (case 3). The detailed results were listed in
Table 3.
Gains of chromosomes 7, 17 and loss of Y which are
characteristic of PRCC, were observed in two cases of
sPRCC and one MTSC (case 1) (Figure 4). However,
case 2 showed no gains of chromosomes 7, 17 and loss
of Y. The detailed results were listed in Table 4.
Follow-up
During the follow-up examinations at 8 and 14 months,
all four patients were alive with no evidence of recurrenceTable 3 Immunohistochemical data of two cases of MTSC and
case AMACR CK CK7 CK19 HMWK
MTSC 1 + + + + +
2 + + + + +
sPRCC 3 + + + + +
4 + + + + -
case NSE villin CD56 CgA Syn
MTSC 1 + - - - -
2 + - - - -
sPRCC 3 - - - - -
4 - - - - -or metastasis postoperatively. The patients continue to be
followed up.
Discussion
Our results proved that MTSC and sPRCC have overlap-
ping morphological and immunohistochemical markers,
including macroscopically, both of MTSC and sPRCC
are well circumscribed, the cut surfaces are greyish-white
in color. Histologically, these two kinds of tumors were
both predominantly composed of tubular areas with a
focal spindle cell appearance; tumor cells showed low nu-
clear grade; mucinous component, papillary architecture
and foamy macrophages could be seen in both. Immuno-
histochemical assay demonstrated that the tumor cells of
MTSC and sPRCC were positive for AMACR, CK, CK7,
CK19, EMA, HMWK, E-cadherin, vimentin and Ki - 67
index was <5%. These results were similar to the previous
studies [7-10,13]. Whereas some differences were ob-
served such as psammoma bodies was only seen in
sPRCC (case 3) and two cases of MTSC were negative forsPRCC
EMA E-ca vim Ki-67 CD10 AB RCC
+ + + +,<5% - AB+ -
+ + + +,<1% - AB+ -
+ + + +,<1% - AB+ -






Figure 4 Molecular genetics of two cases of MTSC. (a): FISH showed gains of chromosomes 7 (blue signal) and 17 (red signal) (arrow) in case 1.
(b): FISH showed loss of chromosome Y (red signal) in case 1. (c): FISH showed normal chromosomes 7, 17. (d): FISH showed normal X chromosome.
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sented in classic MTSC and some cases of MTSC positive
expression of CD10 and RCC were reported [5,7,8,10].
These findings suggested that MTSC and sPRCC have
similar morphological and immunohistochemical features.
Other differences were also observed such as the presence
of a fibrous septum and nuclear grooves in sPRCC, which
were not observed in MTSC. Two cases of MTSC were
focally positive for NSE, which was consistent with the
findings of some researchers reported that MTSC had
neuroendocrine differentiation [14-16]. This change was
not seen in sPRCC. However we did not find out that a
fibrous septum, nuclear grooves and positivity for NSE
could distinguish MTSC from sPRCC.Table 4 Number and percentage of nuclei with fluorescent
hybridization signals









1 7 13(21.66) 24(40.00) 17(28.33) 6(10.00)
17 10(16.66) 31(51.66) 8(13.33) 11(18.33)
Y 5(8.33) 0 0 0
2 7 17(28.33) 42(70.00) 1(1.666) 0
17 19(31.66) 39(65.00) 2(3.33) 0
Y - - - -
3 7 8(13.33) 35(58.33) 7(11.66) 7(11.66)
17 9(15.00) 34(56.66) 13(21.66) 4(6.66)
Y 9(15.00) 0 0 0
4 7 9(15.00) 26(43.33) 20(33.33) 5(8.33)
17 6(10.00) 36(60.00) 8(13.33) 10(16.66)
Y 7(11.66) 0 0 0Molecular genetic analyses were performed to further
evaluate these four cases. We found that case 1 (MTSC)
and two cases of sPRCC both had gains of chromosomes 7
and 17 and loss of the Y chromosome. The results sug-
gested that MTSC and sPRCC could have similar chromo-
somal abnormalities. A review of the literature indicated
that MTSC was characterized by a variety of chromosomal
abnormalities, including frequently losses of chromosomes
1, 4, 6, 8, 9, 11, 13, 14, 15, and 22 and gains of chromo-
somes 2, 5, 7, 9, 10, 11, 12, 16, 17, 18, 19, 20, 21, 22 and X
[16-23]. Rakozy et al. [18] first demonstrated that MTSC
showed losses of chromosomes 1, 4, 6, 8, 9, 13, 14, 15
and 22. Similar results had been reported subsequently.
However Cossu-Rocca et al. [23] analyzed 10 cases of
MTSC using interphase fluorescence in situ hybridization
and showed lack of gains of chromosomes 7, 17 and loss of
Y. In contrast, using comparative genomic hybridization
(CGH), gains of chromosomes 7 and 17 were reported by
others [16,17,19,21,22], but loss of the Y chromosome was
never reported. The present study is the first reported case
of MTSC which have loss of the Y chromosome. Compared
with MTSC, a variety of chromosomal abnormalities in
PRCC were reported, including losses of chromosomes 1,
4, 6, 9, 11, 13, 14, 18, Y and gains of chromosomes 7, 12,
16, 17, and 20 [24,25]. Jiang et al. [25] reported that typic-
ally, PRCC has gains of chromosomes 7, 16, 17 and fre-
quently losses of chromosomes 1, 4, 6, 9, 13, 14, 18, X and
Y. These findings provided evidence that MTSC has similar
cytogenetic aberrations as those of PRCC showing. So we
considered that genetically, MTSC was similar to PRCC.
MTSC is a low-grade malignant tumor, and only a few
cases have been reported [26] that showed metastasis.
sPRCC is similar, often presenting as a low-level renal
tumor of low-clinical stage [27].
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morphologic, immunophenotypic, molecular genetics and
prognostic features show an overlap between MTSC with
sPRCC. Therefore we conclude that MTSC is similar to
sPRCC and may be a subtype of PRCC.
Conclusion
MTSC and sPRCC have overlapping morphological
and immunohistochemical markers, including a tubular
structure, papillary architecture, spindle cell appearance,
psammoma bodies, foamy macrophages, mucin and posi-
tive staining for vimentin, CK7, CK19, EMA, AMACR,
CD10, and RCC. In addition, our results indicated that
MTSC and sPRCC have similar chromosomal abnormal-
ities. Therefore we conclude that MTSC is similar to
sPRCC and maybe a subtype of PRCC. Because of the
small number of cases reported, additional studies are ne-
cessary to confirm our conclusions.
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